Juvenile myoclonic epilepsy (JME) is characterised by generalised onset seizures, often occurring soon after awakening, involving myoclonic seizures predominantly in the arms, and typically without disturbance of consciousness [1]. Myoclonic seizures in JME start to occur around puberty [1–3]. This type of epilepsy is possibly associated with genetic factors and, if correctly diagnosed and with appropriate treatment, can be well controlled [4–6]. Treatment for JME is long term, continuous and pharmacological [7].
11
ABR
ABR
0